# Histological Tissue Response to Calcium Silicate-Based Cements Assessed in Human Tooth Culture Models: A Systematic Review

**Authors:** Alberto Cabrera-Fernández, Hebertt Gonzaga dos Santos Chaves, Aránzazu Díaz-Cuenca, Juan J. Segura-Egea, Jenifer Martín-González, João Peça, Diana B. Sequeira, João Miguel Marques dos Santos

PMC · DOI: 10.3390/jfb17020078 · 2026-02-06

## TL;DR

This review evaluates how human tooth cultures respond to calcium silicate-based cements used in dental treatments, finding that some types consistently promote healing and mineralization.

## Contribution

The study systematically reviews histological responses to calcium silicate-based cements in human tooth culture models, comparing hydraulic and resin-modified types.

## Key findings

- Hydraulic calcium silicate cements like Biodentine and ProRoot MTA consistently induce biocompatible pulp responses and mineralization.
- Resin-modified cements like TheraCal LC show variable and less consistent histological outcomes compared to hydraulic cements.
- Immunohistochemistry supports odontoblast-like differentiation in response to hydraulic cements.

## Abstract

Ex vivo human tooth culture models preserve the native dentine–pulp complex and offer a translational platform to study pulp-capping biomaterials. This systematic review aimed to synthesize the evidence on histological pulp tissue responses to calcium silicate-based cement (CSCs) used for direct pulp capping in human tooth culture models. The review followed PRISMA 2020 guidance. Eligible studies were ex vivo whole human tooth culture models with direct pulp exposure treated with commercial or experimental CSCs and reporting histological outcomes. Risk of bias was assessed using the QUIN tool. Thirteen studies were included. Most used immature human third molars (from 15- to 19-year-old patients) and culture periods up to 28 days, with a minority extending observation to 45–90 days. Across hydraulic CSCs, Biodentine was the most frequently evaluated material, followed by ProRoot MTA and several experimental hydraulic and resin-modified formulations. Overall, hydraulic CSCs were consistently associated with biocompatible pulp responses and a pro-mineralization pattern characterized by periexposure mineralized foci/osteodentin-like tissue; where assessed, immunohistochemistry supported odontoblast-like differentiation. In contrast, the resin-modified CSC TheraCal LC and other experimental resin-modified CSCs showed more heterogeneous findings, with reports of absent, delayed, or less prominent mineralization compared with reference hydraulic CSCs. In intact human tooth culture models, hydraulic CSCs show reproducible biocompatibility and early mineralization features consistent with reparative dentinogenesis, whereas resin-modified CSCs demonstrate more variable histological performance.

## Linked entities

- **Chemicals:** Biodentine (PubChem CID 25523)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, SPARC (secreted protein acidic and cysteine rich) [NCBI Gene 6678] {aka BM-40, OI17, ON, ONT}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, DSPP (dentin sialophosphoprotein) [NCBI Gene 1834] {aka DFNA39, DGI1, DMP3, DPP, DSP}, NES (nestin) [NCBI Gene 10763] {aka Nbla00170}
- **Diseases:** fracture (MESH:D050723), chronic inflammation (MESH:D007249), injury to (MESH:D014947), hypoxia (MESH:D000860), hyperemia (MESH:D006940), pulpal injury (MESH:D003784), cytotoxic (MESH:D064420), tooth discoloration (MESH:D014075), necrosis (MESH:D009336), pulpitis (MESH:D011671)
- **Chemicals:** Calcium Silicate (MESH:C031293), streptomycin (MESH:D013307), tideglusib (MESH:C520571), dicalcium silicate (MESH:C013481), TCS (MESH:D013667), P (MESH:D010758), MTA (MESH:C086631), PT (MESH:D010984), calcium phosphate (MESH:C020243), alpha-MEM (MESH:C420642), MTT (MESH:C070243), pachymic acid (MESH:C102487), beta-glycerophosphate (MESH:C031463), Ca(OH)2 (MESH:D002126), hematoxylin (MESH:D006416), penicillin (MESH:D010406), H&amp;E (MESH:D006371), S (MESH:D013455), Masson's trichrome (-), Bi2O3 (MESH:C033301), eosin (MESH:D004801), OH- (MESH:C031356), ZrO2 (MESH:C028541), Biodentine (MESH:C506393), C2S (MESH:C023714)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Ca(OH)2 — Homo sapiens (Human), Plasma cell myeloma, Cancer cell line (CVCL_5442), TheraCal LC — Homo sapiens (Human), Lung squamous cell carcinoma, Cancer cell line (CVCL_3008)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942347/full.md

---
Source: https://tomesphere.com/paper/PMC12942347